Calyx, formerly Parexel Informatics,[5] is a corporate spin-off from Parexel International.[2][6] Calyx is a British–American provider of biopharmaceutical services.[7] The company was formed in January 2021 following the strategic separation of the Parexel Informatics business from Parexel International, and provides medical imaging, e-clinical and regulatory services.[8]
Company type | Private |
---|---|
Industry | Clinical research organizations Pharmaceutical |
Founded | 2021 |
Headquarters | Nottingham, United Kingdom[1] |
Number of locations | 12+ facilities in 10+ countries |
Key people | CEO: David Herron |
Services | Medical imaging, clinical trial management systems |
Revenue | $82 million (2022)[2][3] |
Number of employees | 1000-2000[4] |
Website | calyx |